Första AP-fonden’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.28M Sell
15,000
-1,000
-6% -$219K 0.02% 459
2025
Q1
$3.58M Sell
16,000
-300
-2% -$67.2K 0.03% 448
2024
Q4
$5.34M Sell
16,300
-300
-2% -$98.3K 0.04% 386
2024
Q3
$4.98M Sell
16,600
-1,400
-8% -$420K 0.04% 395
2024
Q2
$5.93M Sell
18,000
-1,400
-7% -$461K 0.05% 318
2024
Q1
$7.68M Buy
19,400
+4,700
+32% +$1.86M 0.07% 299
2023
Q4
$5.18M Sell
14,700
-800
-5% -$282K 0.05% 347
2023
Q3
$5.82M Sell
15,500
-600
-4% -$225K 0.06% 305
2023
Q2
$6.16M Sell
16,100
-200
-1% -$76.5K 0.07% 309
2023
Q1
$5.65M Sell
16,300
-26,800
-62% -$9.29M 0.07% 320
2022
Q4
$10.1M Buy
43,100
+16,400
+61% +$3.86M 0.11% 199
2022
Q3
$6.57M Buy
26,700
+7,300
+38% +$1.8M 0.08% 274
2022
Q2
$5.87M Sell
19,400
-11,700
-38% -$3.54M 0.08% 303
2022
Q1
$12.8M Sell
31,100
-4,000
-11% -$1.64M 0.15% 153
2021
Q4
$16.5M Buy
35,100
+9,300
+36% +$4.36M 0.17% 126
2021
Q3
$11M Sell
25,800
-7,300
-22% -$3.1M 0.12% 190
2021
Q2
$11.9M Sell
33,100
-6,500
-16% -$2.33M 0.14% 165
2021
Q1
$11.2M Buy
39,600
+9,100
+30% +$2.56M 0.16% 148
2020
Q4
$8.64M Buy
30,500
+11,000
+56% +$3.12M 0.13% 172
2020
Q3
$5.36M Buy
19,500
+7,000
+56% +$1.92M 0.11% 191
2020
Q2
$2.84M Buy
12,500
+2,100
+20% +$477K 0.07% 291
2020
Q1
$1.58M Buy
+10,400
New +$1.58M 0.06% 379